Turalio 125 mg/1
pexidartinib hydrochloride · CAPSULE · Daiichi Sankyo Inc.
Turalio (pexidartinib hydrochloride) is an oral capsule taken by mouth to treat tenosynovial giant cell tumor, a type of tumor that grows in the lining of joints, tendons, and bursae. It works by blocking certain proteins involved in the growth of these tumors.
Key Facts
- Brand Name
- Turalio
- Generic Name
- pexidartinib hydrochloride
- NDC Code (Product)
65597-407- Manufacturer
- Daiichi Sankyo Inc.
- Strength
- 125 mg/1
- Dosage Form
- CAPSULE
- Route
- ORAL
- Marketing Status
- Application #
- NDA211810
- Marketing Start
- 02/01/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Turalio used for?
Turalio (pexidartinib hydrochloride) is an oral capsule taken by mouth to treat tenosynovial giant cell tumor, a type of tumor that grows in the lining of joints, tendons, and bursae. It works by blocking certain proteins involved in the growth of these tumors.
Is Turalio a controlled substance?
Turalio is not classified as a controlled substance by the DEA.
What is the generic name for Turalio?
The generic name for Turalio is pexidartinib hydrochloride. There are no other listed brand versions of pexidartinib hydrochloride.
What is the NDC code for Turalio 125 mg/1?
The NDC (National Drug Code) for Turalio 125 mg/1 is 65597-407, listed by Daiichi Sankyo Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)